Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Siu

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2006
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimusI Duran, L L Siu, A M Oza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyM L Rothenberg, J V Cox, C Butts, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot studyT Spence, N Stickle, C Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)C Kollmannsberger, H Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2007
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancerE Calvo, S N Malik, L L Siu, et al.
British Journal of Cancer|October 25, 2017
Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic reviewA Prawira, S F Oosting, T W Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming unitsL L Siu, G Attardo, E Izbicka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2006
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimusI Duran, L L Siu, A M Oza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyM L Rothenberg, J V Cox, C Butts, et al.
Current Oncology (Toronto, Ont.)|January 4, 2020
Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot studyT Spence, N Stickle, C Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)C Kollmannsberger, H Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2007
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancerE Calvo, S N Malik, L L Siu, et al.
British Journal of Cancer|October 25, 2017
Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic reviewA Prawira, S F Oosting, T W Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming unitsL L Siu, G Attardo, E Izbicka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
Pageof 9